Acute treatment and rapid treatment of headache using Anti-CGRP antibodies

GEP20267919BActive Publication Date: 2026-08-10H LUNDBECK AS

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: GEP20267919P0
Authority / Receiving Office: GE · GE
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2019-07-11
Filing Date: 2020-01-08
Publication Date: 2026-08-10
Estimated Expiration: 2040-01-08

Application Information

Patent Timeline

11 Jul 2019

Priority

08 Jan 2020

Application

GEP20267919P0

10 Aug 2026

Publication

GEP20267919B

IPC: A61K39/00

CPC: A61P25/06; C07K16/18; C07K2317/76; C07K2317/24; C07K2317/71; C07K2317/41; C07K2317/526; A61K2039/505

Inventors: SMITH Jeffrey T.L.; MEHTA Lahar

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

An invention relates to anti-CGRP antibodies for the treatment of acute migraine, when a patient already has migraine, and from beginning of migraine within 30 hours. s

Need to check novelty before this filing date? Find Prior Art